Document is current
Any future updates will be listed below
-
Authors
Inojosa, Hernan
Gilbert, Stephen
Kather, Jakob Nikolas
Proschmann, Undine
Akgün, Katja
Ziemssen, Tjalf http://orcid.org/0000-0001-8799-8202
- License Information
-
More Information
Article History
Received: 6 June 2023
Accepted: 20 July 2023
First Online: 31 August 2023
Declarations
:
: Not applicable.
: Not applicable.
: HI received speaker honoraria from Roche and financial support for research activities from Teva, Biogen and Alexion. SG has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd.; Flo Health Ltd, and Thymia Ltd., FORUM Institut für Management GmbH, High-Tech Gründerfonds Management GmbH, Ada Health GmbH and holds share options in Ada Health GmbH. JNK reports consulting services for Owkin, France, Panakeia, UK and DoMore Diagnostics, Norway and has received honoraria for lectures by MSD, Eisai and Fresenius. UP received personal compensation from Bayer, Biogen and Roche for the consulting service. KA received personal compensation from Novartis, Biogen Idec, Teva, Sanofi and Roche for the consulting service. TZ reports scientific advisory board and/or consulting for Biogen, Roche, Novartis, Celgene, and Merck; compensation for serving on speakers bureaus for Roche, Novartis, Merck, Sanofi, Celgene, and Biogen; research support from Biogen, Novartis, Merck, and Sanofi.
